Stock market spike as Moderna reveals ’Positive’ data in Covid-19 vaccine trial

Stock market spike as Moderna reveals ’Positive’ data in Covid-19 vaccine trial

Boston biopharmaceutical Moderna announced on Monday that a ’positive’ data was been received from an early-stage human trial of a Covid-19 vaccine. Of the 45 participants inducted in the human trial, the data showed COVID-19 antibodies in all of them. As a reaction to this, the Dow Futures was up over 550 points; the S&P 500 was up over 60 points, and the NASDAQ over 165 before opening bell.

Milan
Milan
Top in Business
Get the App